BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Calcaterra I, Ambrosino P, Vitelli N, Lupoli R, Orsini RC, Chiurazzi M, Maniscalco M, Di Minno MND. Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers. Biomedicines 2021;9:122. [PMID: 33513790 DOI: 10.3390/biomedicines9020122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Khefacha L, Rassas R, Bergaoui H, Mustapha H, Faleh R, Sakly N, Sassi M. Antiphospholipid antibodies in the obstetric antiphospholipid syndrome: Detection and antibodies profile at the Maternity and Neonatal Medicine Center of Monastir, Tunisia. J Obstet Gynaecol Res 2022. [PMID: 35042279 DOI: 10.1111/jog.15143] [Reference Citation Analysis]
2 Su Z, Huang Z, Zhao J, Li M, Hu J, Zeng X, Hu C, Yang B. Detection of IgA Antiphospholipid Antibodies Does not Improve Thrombotic Antiphospholipid Syndrome Classification: A two-Center Study. Clin Appl Thromb Hemost 2022;28:10760296221081129. [PMID: 35379020 DOI: 10.1177/10760296221081129] [Reference Citation Analysis]
3 Gil-Etayo FJ, Garcinuño S, Lalueza A, Díaz-Simón R, García-Reyne A, Pleguezuelo DE, Cabrera-Marante O, Rodriguez-Frias EA, Perez-Rivilla A, Serrano M, Serrano A. Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor. Biomedicines 2021;9:899. [PMID: 34440103 DOI: 10.3390/biomedicines9080899] [Cited by in F6Publishing: 2] [Reference Citation Analysis]